Search - tctmd.com

Displaying 561 - 580 of 1060

Sort: Relevancy | Date

News Daily News

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Michael O'Riordan

May 04, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

Caitlin E. Cox

April 24, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Caitlin E. Cox

April 03, 2020

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

Todd Neale

March 27, 2020

News Daily News

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Yael L. Maxwell

March 26, 2020

News Daily News

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

L.A. McKeown

March 25, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

Missed Opportunities: Many HF Patients Not Tested for CAD

L.A. McKeown

March 20, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

Intensive BP Control Lengthens Life: SPRINT Analysis

Todd Neale

March 03, 2020

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Shelley Wood

February 26, 2020

News Daily News

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Shelley Wood

February 14, 2020

News Daily News

Nearly Half of Diabetic Patients Struggle to Pay Medical Bills

Michael O'Riordan

February 12, 2020

News Daily News

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Yael L. Maxwell

February 12, 2020

Advertisement

Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

COVID-19 Drug Candidates May Raise Arrhythmia Risk

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice

Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Missed Opportunities: Many HF Patients Not Tested for CAD

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Intensive BP Control Lengthens Life: SPRINT Analysis

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Snapshot of Revascularization Outcomes Offers Some Reassurances, Some Surprises

Nearly Half of Diabetic Patients Struggle to Pay Medical Bills

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content